Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland. - Publication - Authors - KSSG Research Database

Publication

Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland.

Journal Paper/Review - Jun 10, 2022

Brock Elisabeth, Moschovitis Giorgio, Maeder Micha, Pfister Otmar

Brock, Elisabeth

Moschovitis, Giorgio

Maeder, Micha

attending physician
Kardiologie · Dept. I

Pfister, Otmar